Osiaevi, Irina
Schulze, Arik
Evers, Georg
Harmening, Kimon
Vink, Hans
Kümpers, Philipp
Mohr, Michael
Rovas, Alexandros
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (KU 2873/3-1, ZA428/18-1)
Innovative Medical Research (I-RO221907)
Universitätsklinikum Münster
Article History
Received: 15 May 2022
Accepted: 18 July 2022
First Online: 11 August 2022
Declarations
:
: IO, AS, GE, KH, PK, MM and AR declare that they have no competing interests. HV is Chief Science Officer of GlycoCheck™ BV, The Netherlands. GlycoCheck™ and MVHS™ are trademarks registered by Microvascular Health Solutions LLC (Alpine, UT, United States).
: The study was performed in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the General Medical Council Westfalen-Lippe and the WWU Münster, Germany (file number: Ref. 2020-585-f-S & amendments of Ref. 2016-073-f-S).
: Written informed consent has been obtained from all individuals.